AEON Biopharma Inc - Termination of Peter Reynolds as CFO, Principal Financial Officer and Principal Accounting Officer, Effective as of May 17, 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.